Cancer-treatment startup founded by Duke professors raises $70 million from investors
Xiling Shen, David Hsu, and Hans Clevers, is creating what it calls MicroOrganoSphere technology, or MOS, which takes tissue samples from cancer … Read more
Cancer-treatment startup founded by Duke professors raises $70 million from investors
Xiling Shen, David Hsu, and Hans Clevers, is creating what it calls MicroOrganoSphere technology, or MOS, which takes tissue samples from cancer … Read more
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
